Cargando…

The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs

The coronavirus disease 2019 (COVID-19) represents a global public health burden. In addition to vaccination, safe and efficient antiviral treatment strategies to restrict the viral spread within the patient are urgently needed. An alternative approach to a single-drug therapy is the combinatory use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schreiber, André, Ambrosy, Benjamin, Planz, Oliver, Schloer, Sebastian, Rescher, Ursula, Ludwig, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506552/ https://www.ncbi.nlm.nih.gov/pubmed/36145524 http://dx.doi.org/10.3390/pharmaceutics14091776

Ejemplares similares

The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
por: Schreiber, André, et al.
Publicado: (2022)

Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans
por: Koch-Heier, Julia, et al.
Publicado: (2022)

Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats
por: Füll, Yvonne, et al.
Publicado: (2022)

Improved in vitro Efficacy of Baloxavir Marboxil Against Influenza A Virus Infection by Combination Treatment With the MEK Inhibitor ATR-002
por: Hamza, Hazem, et al.
Publicado: (2021)

Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
por: Brunotte, Linda, et al.
Publicado: (2021)

Repurposing Antifungals for Host-Directed Antiviral Therapy?
por: Schloer, Sebastian, et al.
Publicado: (2022)

MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases
por: Ludwig, Stephan, et al.
Publicado: (2023)

Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection
por: Schloer, Sebastian, et al.
Publicado: (2020)

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro
por: Schloer, Sebastian, et al.
Publicado: (2021)

The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo
por: Schloer, Sebastian, et al.
Publicado: (2019)

Annexins in Translational Research: Hidden Treasures to Be Found
por: Schloer, Sebastian, et al.
Publicado: (2018)

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
por: Schloer, Sebastian, et al.
Publicado: (2020)

Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2
por: Hoffmann, Helen, et al.
Publicado: (2023)

The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model
por: Schloer, Sebastian, et al.
Publicado: (2019)

Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound
por: Bruchhagen, Christin, et al.
Publicado: (2018)

Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro
por: Kummer, Susann, et al.
Publicado: (2022)

Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
por: Matos, Aline da Rocha, et al.
Publicado: (2019)

Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells
por: Krischuns, Tim, et al.
Publicado: (2018)

Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients
por: Scheuch, Gerhard, et al.
Publicado: (2018)

Establishment of a novel method to assess MEK1/2 inhibition in PBMCs for clinical drug development
por: Schüssele, Lara M., et al.
Publicado: (2022)

Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
por: Faist, Aileen, et al.
Publicado: (2023)

3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases
por: Schloer, Sebastian, et al.
Publicado: (2022)

Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells
por: Kroll, Marie-Kristin, et al.
Publicado: (2023)

Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivo
por: Haasbach, Emanuel, et al.
Publicado: (2014)

OR2-002 – The risk of FMF in MEFV heterozygotes
por: Jéru, I, et al.
Publicado: (2013)

Anti-viral approaches against influenza viruses
por: Pleschka, Stephan, et al.
Publicado: (2006)

The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells
por: Eierhoff, Thorsten, et al.
Publicado: (2010)

Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug
por: Droebner, Karoline, et al.
Publicado: (2017)

Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose
por: LeCher, Julia C., et al.
Publicado: (2019)

Mek1 and Mek2 Functional Redundancy in Erythropoiesis
por: Beuret, Laurent, et al.
Publicado: (2021)

Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells
por: Sturm, Max-Johann, et al.
Publicado: (2023)

ATR acts stage specifically to regulate multiple aspects of mammalian meiotic silencing
por: Royo, Hélène, et al.
Publicado: (2013)

Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers
por: Hata, Aaron N, et al.
Publicado: (2017)

Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells
por: Kan, Guangyan, et al.
Publicado: (2021)

Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
por: Demarest, James F., et al.
Publicado: (2022)

Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy
por: Li, Yanan, et al.
Publicado: (2019)

Annexin A6-Balanced Late Endosomal Cholesterol Controls Influenza A Replication and Propagation
por: Musiol, Agnes, et al.
Publicado: (2013)

Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling
por: Pupjalis, Danute, et al.
Publicado: (2011)

Higgs Boson Searches at LHC 002
por: Vivarelli, I
Publicado: (2002)

OR6-002 – Thromboembolism in autoinflammatory syndromes
por: Vaitla, PM, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t4c2isgs061llgf5ekt997hf4d